Insider transactions Merck KGaA

Stocks

Real-time Estimate Tradegate Other stock markets 12:04:20 15/07/2026 BST			5-day change	1st Jan Change
139.75 ^EUR	+0.18%		+0.47%	+14.03%

07-14	Where would AI lead Pharma in the long run?
07-14	Merck Receives European Commission Approval For Erbitux In Combination With Encorafenib And FOLFOX For First-Line Treatment Of Metastatic Colorectal Cancer With BRAF V600E Mutation	CI

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
03-24	Belén Garijo López	Buy	Chief Executive Officer	3,386	103.53	351K	0.0026%
03-24	Helene von Roeder	Buy	Chief Financial Officer	4,563	103.53	472K	0.0035%
26/03/25	Belén Garijo López	Buy	Chief Executive Officer	2,341	130.61	306K	0.0018%
26/03/25	Matthias Heinzel	Buy	Executive/Senior Manager	4,507	130.61	589K	0.0035%
26/03/25	Michaela Freifrau von Glenck	Buy		1,401	130.61	183K	0.0011%
26/03/25	Peter Guenter	Buy	Executive/Senior Manager	4,507	130.61	589K	0.0035%
26/03/24	Peter Guenter	Buy	Executive/Senior Manager	3,884	159.24	619K	0.0030%
26/03/24	Matthias Heinzel	Buy	Executive/Senior Manager	3,884	159.24	619K	0.0030%
28/03/23	Matthias Heinzel	Buy	Executive/Senior Manager	1,684	172.63	291K	0.0013%
28/03/23	Belén Garijo López	Buy	Chief Executive Officer	636	172.63	110K	0.0005%
12/05/22	Belén Garijo López	Buy	Chief Executive Officer	239,944	159.96	38.38M	0.1857%
22/12/21	Belén Garijo López	Buy	Chief Executive Officer	1,550	220.00	341K	0.0012%
23/09/21	Marcus Kuhnert	Buy	Chief Financial Officer	1,000	199.32	199K	0.0008%